Anant Labs

Selumetinib

CAS 606143-52-6

Overview

Selumetinib was originally developed as a treatment for cancers like melanoma, pancreatic cancer, colorectal cancer, and non-small cell lung

Anant Labs manufacture and furnish high quality Selumetinib impurities for global markets. Our Selumetinib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

Selumetinib
In Stock

Selumetinib

CAS 606143-52-6In Stock
WhatsApp
Technical Data
CAS606143-52-6
Mol. FormulaC17H15BrClFN4O3
Mol. Weight457.687 g/mol
IUPAC6-(4-bromo-2-chloroanilino)-7-fluoro-N-(2-hydroxyethoxy)-3-methylbenzimidazole-5-carboxamide
SMILESCN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO
InChIInChI=1S/C17H15BrClFN4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,22,25H,4-5H2,1H3,(H,23,26)
InChI KeyCYOHGALHFOKKQC-UHFFFAOYSA-N

Note: We are upgrading our system, Cat No will change.

Synonyms
Selumetinib606143-52-6AZD6244ARRY-1428865-[(4-BROMO-2-CHLOROPHENYL)AMINO]-4-FLUORO-N-(2-HYDROXYETHOXY)-1-METHYL-1H-BENZIMIDAZOLE-6-CARBOXAMIDEAZD 6244AZD-6244ARRY-886selumetinibumDTXSID3048944

Looking for a specific reference standard?

Tell us what you need. Our team responds within one business day.